Clinical Trials Directory

Trials / Completed

CompletedNCT02982993

Hepatitis C Infection in World Trade Center Responders

Status
Completed
Phase
Study type
Observational
Enrollment
3,906 (actual)
Sponsor
Icahn School of Medicine at Mount Sinai · Academic / Other
Sex
All
Age
51 Years – 72 Years
Healthy volunteers
Accepted

Summary

This study provides Hepatitis C virus screening to the members of the World Trade Center Health Program followed at the Icahn School of Medicine at Mount Sinai born during 1945-1965, and linkage to care for those found infected. The study will also determine if exposure to human remains, blood and/or bodily fluids during the World Trade Center Health Program activities are associated with Hepatitis C virus infection. These findings would be relevant to the larger United States population, especially to persons born during 1945-1965 who are at high risk of Hepatitis C virus infection.

Detailed description

The purpose of the project is to determine if the World Trade Center Health Program cohort is at an increased risk of Hepatitis C virus infection, determine if human exposure to human remains, blood and/or body fluids during the World Trade Center recovery activities is associated with increased risk of Hepatitis C virus infection, and to determine if referral to a co-located site for Hepatitis C virus care is associated with improved linkage to Hepatitis C virus care in the members of the World Trade Center Health Program born during 1945 through 1965.

Conditions

Timeline

Start date
2016-12-01
Primary completion
2018-07-12
Completion
2018-07-12
First posted
2016-12-06
Last updated
2019-02-04

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02982993. Inclusion in this directory is not an endorsement.